Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Immutep Limited - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immutep Limited - ADR market cap is $240.73M.
What is the 52-week high for Immutep Limited - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immutep Limited - ADR 52 week high is $2.71 as of September 13, 2025.
What is the 52-week low for Immutep Limited - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immutep Limited - ADR 52 week low is $1.32 as of September 13, 2025.
What is Immutep Limited - ADR stock price today?
Immutep Limited - ADR stock price today is $1.64.
What was Immutep Limited - ADR stock price yesterday?
Immutep Limited - ADR stock price yesterday was $1.66.
What is the PE ratio of Immutep Limited - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Immutep Limited - ADR’s P/E ratio is -6.03.
What is the Price-to-Book ratio of Immutep Limited - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Immutep Limited - ADR P/B ratio is 2.5444.
What is the 50-day moving average of Immutep Limited - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immutep Limited - ADR 50-day moving average is $1.70.
